tiprankstipranks
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
US Market

Upstream Bio, Inc. (UPB) Financial Statements

Compare
18 Followers

Upstream Bio, Inc. Financial Overview

Upstream Bio, Inc.'s market cap is currently $368.51M. The company's EPS TTM is $; its P/E ratio is ―; Upstream Bio, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23
Income Statement
Total Revenue
Gross Profit$ 2.38M
Operating Income$ -40.11M
EBITDA$ -21.74M
Net Income$ -20.54M
Balance Sheet
Cash & Short-Term Investments$ ―
Total Assets$ 117.20M
Total Debt$ 45.00K
Net Debt$ -109.77M
Total Liabilities$ 9.39M
Stockholders' Equity$ ―
Cash Flow
Free Cash Flow$ -38.07M
Operating Cash Flow$ -37.93M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Upstream Bio, Inc. Earnings and Revenue History

Upstream Bio, Inc. Debt to Assets

Upstream Bio, Inc. Cash Flow

Upstream Bio, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis